Chemical Name: 1-[2-[5-[(3-Methyloxetan-3-yl)methoxy]benzimidazole-1-yl]quinoline-8-yl]piperidin-4-amine. Alternate Names: CP-868,596
PDGFR and FLT3 inhibitor
Molekulargewicht:
443.55
Reinheit:
97% by HPLC NMR (Conforms)
Formulierung:
White solid
CAS Nummer:
[670220-88-9]
Formel:
C26H29N5O2
Anwendungsbeschreibung:
Crenolanib is a potent inhibitor of PDGFR (Kd for alpha = 2.1 nM, ß = 3.2 nM) and FLT3 (Kd = 0.74 nM).1 Crenolanib is a type I inhibitor binding only to the active kinase conformation. It showed potent activity against imatinib-resistant PDGFRalpha mutations D842I, D842V, D842Y, DI842-843M, and deletion I8432 as well as FLT3/ITD and FLT3/D835 mutants3. Crenolanib acted synergistically with FLT3-CAR T-cells in a FLT3-ITD+ AML murine xenograft model.4
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten